Who Paid My Doc
John Rush
Emergency Medicine Spring, TX Medical Doctor
NPI 1851337281 CMS profile 785913
24624 I-45 N, Suite 125, Spring, TX 77386
General payments
$1,746
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, John Rush of Spring, TX is reported in the CMS Open Payments database as having received $1,746 across 15 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 94th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,456 | 6 | |
| 2024 | General | $39 | 2 | |
| 2023 | General | $34 | 1 | |
| 2022 | General | $133 | 3 | |
| 2021 | General | $68 | 2 | |
| 2019 | General | $16 | 1 |
Beside peers
- John Rush
- Emergency Medicine median
- Middle half of Emergency Medicine
- National median
In program year 2025, general payments to John Rush were reported at $1,456. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.
Show as a table
| Year | John Rush | Emergency Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $16 | $51 | $18–$128 | $163 |
| 2020 | $0 | $29 | $16–$99 | $114 |
| 2021 | $68 | $40 | $18–$124 | $132 |
| 2022 | $133 | $49 | $20–$134 | $149 |
| 2023 | $34 | $51 | $22–$142 | $160 |
| 2024 | $39 | $52 | $22–$150 | $164 |
| 2025 | $1,456 | $57 | $24–$150 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 20 billing codesPaid by Medicare
$691,080
Medicare patients
496
Services billed
156,478
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 33% | |
| Ischemic heart disease | 28% | |
| Chronic kidney disease | 26% | |
| Depression | 18% | |
| Atrial fibrillation | 17% | |
| Cancer | 17% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg J7320 | Office | 397 | 53,350 | $226,871 |
| Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml Q9965 | Office | 389 | 80,620 | $93,801 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg J3304 | Office | 81 | 4,480 | $62,037 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose J7321 | Office | 19 | 78 | $4,328 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 | Office | 112 | 12,698 | $3,634 |
| Injection, ketorolac tromethamine, per 15 mg J1885 | Office | 134 | 397 | $185 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
15 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Emergency Medicine in Texas
Related records
Emergency Medicine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Emergency Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.